X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-17-2024-82633.pdf
https://www.moneycontrol.com/news/business/lupin-glenmark-recall-drugs-in-us-market-usfda-12613191.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-7-2024-67267.pdf
https://www.euroapi.com/en/fighting-tuberculosis-EUROAPI-rifampicin-meets-new-requirements-for-nitrosamine-impurity-standards
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-7-2023-80553.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-25-2023-68767.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-18-2023-33998.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-26-2022-89071.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-5-2022-44974.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-24-2022-1661335123.pdf
https://www.raps.org/news-and-articles/news-articles/2020/8/fda-addresses-nitrosamines-in-tb-drugs
https://www.fda.gov/drugs/drug-safety-and-availability/fda-works-mitigate-shortages-rifampin-and-rifapentine-after-manufacturers-find-nitrosamine#:~:text=To%20mitigate%20or%20avoid%20shortages,CPNP)%20above%20the%20acceptable%20intake
https://www.pharmacompass.com/pdf/news/health-canada-issues-recalls-of-bausch-health-canadas-rifampin-1584429253.pdf
https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-rifadin-rifampicin-150mg-capsules-mdr-127-09-19
https://www.evotec.com/en/invest/news--announcements/press-releases/p/evotec-receives--238-m-grant-to-join-the-global-fight-against-tuberculosis-5817
https://www.reuters.com/article/us-tb-alliance-fda/fda-advisory-panel-recommends-approval-of-tb-alliances-tuberculosis-treatment-idUSKCN1T72QP
https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/who-announces-important-changes-to-multi-drug-resistant-tb-treatment/articleshow/65444597.cms
https://pharmaphorum.com/news/new-tuberculosis-drug-could-help-eradicate-global-killer/
https://www.pharmacompass.com/pdf/news/hikma-pharms-generic-rifampin-approved-in-us-as-an-antibiotic-1457523914.pdf
http://www.prnewswire.com/news-releases/viiv-healthcare-announces-phase-ii-study-results-for-first-two-drug-long-acting-injectable-regimen-for-hiv-1-treatment-569850931.html
http://www.newsinferno.com/cholesterol-tb-drugs-recalled-in-the-philippines-due-to-failed-dissolution-tests/?
http://profit.ndtv.com/news/industries/article-drug-regulator-fixes-prices-of-30-formulation-packs-761597
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/antibiotics-made-by-emcure-pharmaceuticals-recalled-in-us/articleshow/46717034.cms
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0416-2015&w=03252015&lang=eng
http://www.financialexpress.com/article/lifestyle/health/hiv-new-compound-may-treat-hiv-drug-resistant-tb/47287/
Market Place
Share 
